Omnimmune Holdings Stock Market Value
| OMMH Stock | USD 0.0001 0.00 0.00% |
| Symbol | Omnimmune |
Omnimmune Holdings Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Omnimmune Holdings. If investors know Omnimmune will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Omnimmune Holdings listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Omnimmune Holdings is measured differently than its book value, which is the value of Omnimmune that is recorded on the company's balance sheet. Investors also form their own opinion of Omnimmune Holdings' value that differs from its market value or its book value, called intrinsic value, which is Omnimmune Holdings' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Omnimmune Holdings' market value can be influenced by many factors that don't directly affect Omnimmune Holdings' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Omnimmune Holdings' value and its price as these two are different measures arrived at by different means. Investors typically determine if Omnimmune Holdings is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Omnimmune Holdings' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Omnimmune Holdings 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Omnimmune Holdings' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Omnimmune Holdings.
| 11/28/2025 |
| 12/28/2025 |
If you would invest 0.00 in Omnimmune Holdings on November 28, 2025 and sell it all today you would earn a total of 0.00 from holding Omnimmune Holdings or generate 0.0% return on investment in Omnimmune Holdings over 30 days. Omnimmune Holdings, Inc., through its subsidiary, Omnimmune Corp., operates as a development-stage biotechnology company... More
Omnimmune Holdings Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Omnimmune Holdings' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Omnimmune Holdings upside and downside potential and time the market with a certain degree of confidence.
Omnimmune Holdings Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Omnimmune Holdings' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Omnimmune Holdings' standard deviation. In reality, there are many statistical measures that can use Omnimmune Holdings historical prices to predict the future Omnimmune Holdings' volatility.Omnimmune Holdings Backtested Returns
We have found three technical indicators for Omnimmune Holdings, which you can use to evaluate the volatility of the company. The company holds a Beta of 0.0, which implies not very significant fluctuations relative to the market. the returns on MARKET and Omnimmune Holdings are completely uncorrelated.
Auto-correlation | 0.00 |
No correlation between past and present
Omnimmune Holdings has no correlation between past and present. Overlapping area represents the amount of predictability between Omnimmune Holdings time series from 28th of November 2025 to 13th of December 2025 and 13th of December 2025 to 28th of December 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Omnimmune Holdings price movement. The serial correlation of 0.0 indicates that just 0.0% of current Omnimmune Holdings price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.0 | |
| Spearman Rank Test | 1.0 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Omnimmune Holdings lagged returns against current returns
Autocorrelation, which is Omnimmune Holdings stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Omnimmune Holdings' stock expected returns. We can calculate the autocorrelation of Omnimmune Holdings returns to help us make a trade decision. For example, suppose you find that Omnimmune Holdings has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Omnimmune Holdings regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Omnimmune Holdings stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Omnimmune Holdings stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Omnimmune Holdings stock over time.
Current vs Lagged Prices |
| Timeline |
Omnimmune Holdings Lagged Returns
When evaluating Omnimmune Holdings' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Omnimmune Holdings stock have on its future price. Omnimmune Holdings autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Omnimmune Holdings autocorrelation shows the relationship between Omnimmune Holdings stock current value and its past values and can show if there is a momentum factor associated with investing in Omnimmune Holdings.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Check out Omnimmune Holdings Correlation, Omnimmune Holdings Volatility and Omnimmune Holdings Alpha and Beta module to complement your research on Omnimmune Holdings. For more detail on how to invest in Omnimmune Stock please use our How to Invest in Omnimmune Holdings guide.You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Omnimmune Holdings technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.